Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) studied for its potential in reducing visceral adiposity and improving metabolic markers. It has been researched in relation to HIV-associated lipodystrophy and age-related fat distribution in preclinical settings. Each vial contains 10mg of Tesamorelin for research purposes.
For in vitro research only. Not for human or veterinary administration.